Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | QDEL | Common Stock | Award | +6.53K | 6.53K | May 27, 2022 | Direct | F1 | |||
transaction | QDEL | Common Stock | Award | +16.6K | 16.6K | May 27, 2022 | UGMA Account | F1, F2 | |||
transaction | QDEL | Common Stock | Award | +38.1K | 38.1K | May 27, 2022 | Birchview | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | QDEL | Non-Qualified Stock Options | Award | $0 | +259 | $0.00 | 259 | May 27, 2022 | Common Stock | 259 | $53.27 | Direct | F4, F5 | |
transaction | QDEL | Restricted Stock Units | Award | $0 | +875 | $0.00 | 875 | May 27, 2022 | Common Stock | 875 | Direct | F6, F7, F8 | ||
transaction | QDEL | Restricted Stock Units | Award | $0 | +262 | $0.00 | 262 | May 27, 2022 | Common Stock | 262 | Direct | F6, F7, F8 | ||
transaction | QDEL | Restricted Stock Units | Award | $0 | +427 | $0.00 | 427 | May 27, 2022 | Common Stock | 427 | Direct | F6, F7, F8 | ||
transaction | QDEL | Restricted Stock Units | Award | $0 | +85 | $0.00 | 85 | May 27, 2022 | Common Stock | 85 | Direct | F6, F7, F8 |
Id | Content |
---|---|
F1 | Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation ("Quidel"), Ortho Clinical Diagnostics Holdings plc, QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each share of common stock of Quidel beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for one share of common stock of QuidelOrtho. |
F2 | The Reporting Person is custodian under the Uniform Gift to Minor Act of 16,630 shares held by four of the Reporting Person's children. The Reporting Person disclaims beneficial ownership of these shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
F3 | The Reporting Person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC in his capacity as the Chief Executive Officer of such entity. The Reporting Person disclaims beneficial ownership of the shares held by Birchview Fund, LLC except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. |
F4 | Pursuant to the Business Combination Agreement, the Quidel Non-Qualified Stock Options were converted into an equal number of Non-Qualified Stock Options to purchase shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). |
F5 | Vested in full. |
F6 | Each restricted stock unit represents the right to receive one share of QuidelOrtho common stock. |
F7 | Pursuant to the Business Combination Agreement, the Quidel restricted stock units were converted into an equal number of restricted stock units representing the right to receive shares of common stock of QuidelOrtho on the same terms and conditions (including applicable vesting conditions). |
F8 | Release of restricted stock units was deferred pursuant to QuidelOrtho's deferred compensation program applicable to participating non-employee directors and will occur according to the elected deferral schedule. |